INMD News and Press, InMode Ltd. From 10/12/23

2023-10-12 08:22:14 ET More on Beyond Meat, SELLAS Life Sciences, etc. Beyond Meat Continues To Look Potentially Beyond Repair Beyond Meat: The Core Question Here Is Liquidity Beyond Meat: Pain Is Far From Over SELLAS gains on FDA orphan drug status for its S...

InMode Expects Third Quarter 2023 Revenue Between $122.8M-$123.0M, Lowering Full-Year 2023 Revenue Guidance to $500M-$510M vs. Original Estimates of $530M-$540M PR Newswire Conference call to be held on Thursday, Nov. 2, 2023, at 8:30 a.m. Eastern Time YOKNEA...

2023-10-09 16:59:45 ET More on InMode InMode: Strong Net Cash Position Sets The Stage For Opportunistic Buybacks InMode: Bullish Support Failed To Materialize InMode: Be Greedy When Others Are Fearful For further details see: InMode does not expect produc...

InMode Affirms Safety of Management, Employees and Production Sites PR Newswire YOKNEAM, Israel , Oct. 9, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, addressed today the status of th...

2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...

2023-10-09 10:14:39 ET More on Conflict Between Israel and Hamas Oil prices pop after Hamas attack on Israel but analysts foresee limited gains Chevron told by Israel to shut down Tamar gas platform War In Israel Spurs Flight To Dollars, Yen And Gold, While Drivi...

2023-10-09 08:23:30 ET More on InMode, Mirati Therapeutics, etc. InMode: Bullish Support Failed To Materialize InMode: Strong Net Cash Position Sets The Stage For Opportunistic Buybacks InMode: Be Greedy When Others Are Fearful Bristol-Myers Squibb to acquire...

2023-09-27 16:00:00 ET Summary While we may have been bullish about INMD's eventual reversal to its historical valuations, it appears that our bullish investment thesis has been temporarily invalidated. This is despite the FQ2'23 double beats, raised FY2023 guidance, and optimisti...

2023-09-27 11:00:00 ET Summary InMode's stock price has dropped significantly from its peak in 2021, despite consistently strong operational performance. In the meantime, the company's strong profitability has led to InMode featuring a substantial cash position relative to its mar...

2023-09-24 13:01:04 ET The growing popularity of GLP-1 weight-loss drugs may be already impacting demand for certain procedures like body contouring and dermo fillers, according to Needham’s Q3 aesthetics procedures survey. Needham asked respondents who were familiar with GLP-1 d...